Zoono Group Ltd
ASX:ZNO
Intrinsic Value
Zoono Group Ltd. is a pharmaceutical and biotechnology company. [ Read More ]
The intrinsic value of one ZNO stock under the Base Case scenario is 0.026 AUD. Compared to the current market price of 0.055 AUD, Zoono Group Ltd is Overvalued by 54%.
Valuation Backtest
Zoono Group Ltd
Run backtest to discover the historical profit from buying and selling ZNO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Zoono Group Ltd
Current Assets | 7.9m |
Cash & Short-Term Investments | 136.3k |
Receivables | 230.7k |
Other Current Assets | 7.6m |
Non-Current Assets | 1.3m |
PP&E | 1.3m |
Intangibles | 1.6k |
Current Liabilities | 1.7m |
Accounts Payable | 706.8k |
Accrued Liabilities | 45.7k |
Other Current Liabilities | 963.6k |
Non-Current Liabilities | 2.1m |
Long-Term Debt | 711.9k |
Other Non-Current Liabilities | 1.3m |
Earnings Waterfall
Zoono Group Ltd
Revenue
|
2.1m
NZD
|
Cost of Revenue
|
-1.2m
NZD
|
Gross Profit
|
935.3k
NZD
|
Operating Expenses
|
-8.5m
NZD
|
Operating Income
|
-7.5m
NZD
|
Other Expenses
|
-125.7k
NZD
|
Net Income
|
-7.7m
NZD
|
Free Cash Flow Analysis
Zoono Group Ltd
ZNO Profitability Score
Profitability Due Diligence
Zoono Group Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
Score
Zoono Group Ltd's profitability score is 23/100. The higher the profitability score, the more profitable the company is.
ZNO Solvency Score
Solvency Due Diligence
Zoono Group Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Score
Zoono Group Ltd's solvency score is 64/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ZNO Price Targets Summary
Zoono Group Ltd
Shareholder Return
ZNO Price
Zoono Group Ltd
Average Annual Return | 161.21% |
Standard Deviation of Annual Returns | 365.39% |
Max Drawdown | -99% |
Market Capitalization | 17.3m AUD |
Shares Outstanding | 314 708 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Zoono Group Ltd. is a pharmaceutical and biotechnology company. The company is headquartered in Sydney, New South Wales. The firm is focused on developing, manufacturing and distributing of scientifically validated antimicrobial solutions. The firm's products are based on the Zoono molecule, which is an antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mould. The firm's products include sprays, wipes and foams suited for skin care, surface sanitizers, and mould remediation treatments. Its sanitizer products include surface sanitizer and hand sanitizer.
Contact
IPO
Employees
Officers
The intrinsic value of one ZNO stock under the Base Case scenario is 0.026 AUD.
Compared to the current market price of 0.055 AUD, Zoono Group Ltd is Overvalued by 54%.